Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Magnum Opus Acquisition $200 million IPO
We advised the underwriters on the SPAC IPO and NYSE listing
Xometry $347.9 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Zylox-Tonbridge Medical Technology HK$2.56 billion IPO
We advised Zylox-Tonbridge Medical Technology on its IPO and HKEX listing
Corporación Acciona Energías Renovables €1.3 billion IPO
We advised Corporación Acciona Energías Renovables on its IPO and Spanish Stock Exchanges listing
Elliott Opportunity II $609.5 million IPO
We advised Elliott Opportunity II Corp., a SPAC, on its IPO and NYSE listing
HUTCHMED HK$4.17 billion IPO and primary listing
The shares are listed on the Hong Kong Stock Exchange
Integral Ad Science Holding $270 million IPO
We advised the underwriters on the IPO and Nasdaq listing
XPO Logistics $794 million follow-on and secondary offering
We advised the underwriters on the SEC-registered stock offering
Bowlero $2.6 billion merger with Isos Acquisition
We advised Atairos on the acquisition
XP $750 million notes offering
We advised XP on its Rule 144A / Regulation S offering of senior unsecured notes